This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miyazaki, H. Articles by Yeudall, W. A. Search for Related Content PubMed PubMed Citation Articles by Miyazaki, H. Articles by Yeudall, W. A.

Down-regulation of CXCL5 Inhibits Squamous Carcinogenesis

¹ Philips Institute, ² Department of Biochemistry, and ³ Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia and ⁴ Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland

Requests for reprints: W. Andrew Yeudall, The Philips Institute of Oral and Craniofacial Molecular Biology, Virginia Commonwealth University, P.O. Box 980566, 521 North 11th Street, Richmond, VA 23298-0566. Phone: 804-828-6415; Fax: 804-828-0150; E-mail: wayeudall{at}vcu.edu.

We report a novel role for the CXC-chemokine, CXCL5, in the proliferation and invasion of head and neck squamous cell carcinoma (HNSCC). Previously, we reported transcriptional up-regulation of CXCL5 in metastatic cells. In this study, we provide biological validation of these findings and show that CXCL5 is intimately involved in tumor cell proliferation, migration, and invasion. Cells derived from a lymph node metastasis, but not from a synchronous primary tumor, secreted CXCL5 as judged by Western blotting of conditioned media. We used RNA interference to generate cell lines (shL5) in which CXCL5 expression was greatly reduced, and tested whether this modulated the cell phenotype. shL5 cells showed decreased proliferation compared with cells harboring nontargeting control sequences. In addition, we found that the ability of shL5 cells to migrate and invade in vitro through a basement membrane substitute was greatly impaired compared with control cells. Finally, whereas control cells were highly tumorigenic in nude mice, the tumorigenic potential in vivo of shL5 cells was found to be ablated. Taken together, these data suggest that CXCL5 production contributes to both enhanced proliferation and invasion of squamous cell carcinomas and that targeting of chemokine pathways may represent a potential therapeutic modality for these lesions. (Cancer Res 2006; 66(8):4279-84)

This article has been cited by other articles:

				R. J. Paccione, H. Miyazaki, V. Patel, A. Waseem, J. S. Gutkind, Z. E. Zehner, and W. A. Yeudall Keratin down-regulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility Mol. Cancer Ther., September 1, 2008; 7(9): 2894 - 2903. [Abstract] [Full Text] [PDF]

				Z. Q. Yuan, L. Nicolson, B. Marchetti, E. A. Gault, M. S. Campo, and L. Nasir Transcriptional Changes Induced by Bovine Papillomavirus Type 1 in Equine Fibroblasts J. Virol., July 1, 2008; 82(13): 6481 - 6491. [Abstract] [Full Text] [PDF]

				F. M. Speetjens, P. J.K. Kuppen, M. H. Sandel, A. G. Menon, D. Burg, C. J.H. van de Velde, R. A.E.M. Tollenaar, H. J.G.M. de Bont, and J. F. Nagelkerke Disrupted Expression of CXCL5 in Colorectal Cancer Is Associated with Rapid Tumor Formation in Rats and Poor Prognosis in Patients Clin. Cancer Res., April 15, 2008; 14(8): 2276 - 2284. [Abstract] [Full Text] [PDF]